Aortic Stenosis / Aortic Sclerosis

🔍 Definition

Aortic stenosis (AS) is a structural heart disease characterized by narrowing of the aortic valve orifice, causing obstruction to left ventricular outflow. It is one of the most prevalent valvular heart diseases in adults, with a prevalence that increases significantly with age. According to the ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease, aortic stenosis is defined hemodynamically by a peak aortic jet velocity ≥ 2.0 m/s with a normal valve area of 3–4 cm² reduced to varying degrees depending on severity.

Aortic sclerosis is an important and distinct precursor condition defined by thickening, calcification, or fibrosis of the aortic valve leaflets without hemodynamically significant obstruction to outflow. By convention, aortic sclerosis does not produce a transvalvular gradient exceeding 10 mmHg and aortic jet velocity remains < 2.0 m/s. It affects approximately 25–30% of adults over age 65 and represents an independent marker of increased cardiovascular risk. Approximately 1–2% of aortic sclerosis cases progress to hemodynamically significant aortic stenosis per year, as documented in longitudinal studies referenced by the American Heart Association.

The coding distinction is clinically critical: aortic sclerosis without obstruction is typically coded to I35.8 (Other nonrheumatic disorders of aortic valve) or managed under an observation/screening Z-code framework, whereas any degree of hemodynamic obstruction (gradient > 10 mmHg; jet velocity ≥ 2.0 m/s) establishes true stenosis and warrants an AS code.

📝 Coder Note

Do not assume “aortic sclerosis” and “aortic stenosis” are interchangeable. Assign I35.8 for documented aortic sclerosis without obstruction; assign I35.0 for nonrheumatic aortic stenosis, or I35.2 when nonrheumatic aortic stenosis with insufficiency/regurgitation is documented. Query the physician if the clinical documentation uses “sclerosis” alone but echocardiographic findings suggest obstruction.

🗂️ Alternative Terminology

The following table maps formal diagnostic terms to the clinical, lay, and colloquial language commonly encountered in chart documentation. Coders and CDI specialists should recognize all variants to ensure accurate code assignment.

Formal / Clinical TermColloquial / Lay / Alternative Terms
Aortic stenosis (AS)Aortic valve stenosis; tight aortic valve; narrowed aortic valve; calcific aortic stenosis (CAS)
Aortic sclerosisAortic valve sclerosis; valve thickening; calcified aortic leaflets (without obstruction); aortic valve calcification (non-obstructive)
Degenerative / calcific aortic stenosisSenile aortic stenosis; age-related AS; calcium-related AS; Monckeberg’s aortic stenosis
Bicuspid aortic valve (BAV) with stenosisTwo-leaflet aortic valve; bicuspid valve disease; BAV stenosis
Rheumatic aortic stenosisRheumatic aortic valve disease; post-rheumatic AS
Congenital aortic stenosisCongenital aortic valve stenosis; valvular congenital AS (Q23.0); subvalvular AS/subaortic membrane (Q24.4); supravalvular AS/SVAS (Q25.3)
Low-flow, low-gradient ASParadoxical AS; pseudo-severe AS; LF-LG AS
Aortic regurgitation / insufficiencyAortic incompetence; leaky aortic valve; AR; AI
Combined aortic stenosis with regurgitationMixed aortic valve disease; AS + AR; stenosis with regurgitation
Post-TAVR statusTranscatheter aortic valve replacement; TAVI; CoreValve; SAPIEN valve
Post-SAVR statusSurgical aortic valve replacement; open-heart valve surgery; bioprosthetic/mechanical valve

🩺 Signs & Symptoms

Aortic stenosis classically presents with the triad of angina, syncope, and heart failure (dyspnea). Symptom onset marks a critical prognostic threshold — untreated symptomatic severe AS carries an average survival of 2–3 years. According to UpToDate: Clinical manifestations and diagnosis of aortic stenosis in adults, key findings include:

  • Angina pectoris — exertional chest pain from subendocardial ischemia due to increased oxygen demand from hypertrophied myocardium; average survival 5 years after onset
  • Syncope / presyncope — exertional dizziness or loss of consciousness from inability to augment cardiac output; average survival 3 years after onset
  • Heart failure / dyspnea — exertional dyspnea, orthopnea, PND due to diastolic and eventually systolic dysfunction; average survival 1–2 years after onset
  • Auscultation — harsh, crescendo-decrescendo systolic ejection murmur at the right upper sternal border, radiating to the carotids; paradoxical splitting of S2; diminished or absent A2; S4 gallop
  • Pulsus parvus et tardus — weak, delayed carotid upstroke on physical exam
  • Reduced pulse pressure — narrow pulse pressure on BP measurement
  • Signs of HF — JVD, crackles, peripheral edema, decreased exercise tolerance

Aortic sclerosis is typically asymptomatic. It may produce a soft systolic murmur (grade I–II/VI) but without hemodynamic compromise, and is often discovered incidentally on echocardiography or auscultation.

⚠️ Common Pitfall

Providers may document a “systolic murmur” or “aortic calcification” without specifying whether stenosis is present. CDI specialists must query for echocardiographic confirmation (peak gradient, mean gradient, valve area, jet velocity) before assigning an AS code. A systolic murmur from sclerosis does not justify coding AS.

🧭 Differential Diagnosis

Accurate differential diagnosis is essential to ensure appropriate ICD-10-CM code assignment. The following conditions may mimic, co-exist with, or be confused with aortic stenosis in clinical documentation.

ConditionKey Distinguishing FeaturesRelevant ICD-10-CM
Aortic sclerosis (non-obstructive)Valve thickening/calcification; gradient ≤ 10 mmHg; jet velocity < 2.0 m/s; no obstructionI35.8
Hypertrophic obstructive cardiomyopathy (HOCM)Dynamic LVOT obstruction; SAM of mitral valve; Brockenbrough sign; septal hypertrophy on echoI42.1, I42.2
Mitral regurgitationHolosystolic murmur at apex radiating to axilla; LA enlargement; no LVOT gradientI34.0
Aortic regurgitation (isolated)Diastolic decrescendo murmur; wide pulse pressure; AR jet on Doppler; no stenotic gradientI35.1
Pulmonary stenosisSystolic murmur at LUSB; RV hypertrophy; Doppler gradient across pulmonic valveI37.0, Q22.1
Subvalvular (discrete membranous) ASFixed LVOT obstruction below aortic valve on imaging; subaortic membrane or fibromuscular ringQ24.4
Supravalvular ASObstruction above valve; Williams syndrome association; “hourglass” aortic root on imagingQ25.3
Rheumatic aortic stenosisHistory of acute rheumatic fever; commissural fusion; concurrent mitral valve diseaseI06.0
Congenital bicuspid aortic valve (without stenosis)Bicuspid morphology on echo; possible aortopathy; may or may not have gradientQ23.81
Heart failure (without valvular etiology)Normal valve function; HFpEF or HFrEF from non-valvular cause; dyspnea may overlapI50.x

📋 Clinical Indicators

The following clinical indicators should prompt code assignment or a CDI query when found in chart documentation, echocardiographic reports, operative notes, or discharge summaries.

Indicator Found in DocumentationCoding/CDI Action
Aortic valve area (AVA) < 1.0 cm² with mean gradient > 40 mmHg or Vmax > 4.0 m/sAssign severe AS (I35.0); confirm with provider if documentation does not use “severe”
AVA 1.0–1.5 cm² with mean gradient 20–40 mmHg or Vmax 3.0–4.0 m/sModerate AS (I35.0); query severity if not documented
AVA > 1.5 cm²; Vmax 2.0–3.0 m/s; gradient < 20 mmHgMild AS (I35.0); may also see “mild aortic stenosis” documented
“Aortic sclerosis” or “valve thickening” with Vmax < 2.0 m/s and no gradient specifiedCode I35.8; do NOT code AS
Bicuspid aortic valve on echocardiography reportAdd Q23.81 (congenital bicuspid AV); query if stenosis is also present (concurrent I35.0)
History of rheumatic fever with aortic valve diseaseUse I06.x category, not I35.x; query for rheumatic etiology if uncertain
Low LVEF (< 50%) with low mean gradient (< 40 mmHg) and small AVA (< 1 cm²)Classic low-flow low-gradient AS; query for “severe AS with reduced LVEF” vs. pseudo-severe AS
Normal LVEF with low gradient but small AVAParadoxical low-flow low-gradient AS; query physician to clarify severity classification
TAVR or SAVR documented in historyAdd Z95.2 (presence of prosthetic heart valve) when supported; do not use Z95.810 for TAVR status because Z95.810 is for presence of an automatic implantable cardiac defibrillator
Concurrent aortic stenosis AND aortic insufficiency/regurgitation documentedAssign I35.2 (nonrheumatic AS with insufficiency) instead of separate codes
Multiple valve disease (AV + MV or AV + TV)Use I08.x codes; I08.0 for MV+AV; I08.2 for AV+TV; I08.3 for MV+AV+TV
Congenital aortic stenosis in pediatric/congenital heart disease contextAssign Q23.0 (not I35.0) for congenital etiology; confirm with cardiologist or surgeon documentation
💬 CDI Query Trigger

When echocardiographic data shows AVA < 1.0 cm² but the provider has not documented severity staging, initiate a compliant query: “Based on the echocardiographic findings (AVA [X] cm², mean gradient [X] mmHg, Vmax [X] m/s), would you characterize the aortic stenosis as mild, moderate, severe, or very severe? Please respond or document your clinical assessment.”

🦴 Anatomy & Pathophysiology

The aortic valve is a semilunar valve consisting of three cusps (left, right, and non-coronary) positioned at the junction of the left ventricular outflow tract (LVOT) and the ascending aorta. Its normal open area is approximately 3.0–4.0 cm². It opens during systole to permit blood ejection from the LV and closes during diastole to prevent regurgitation.

Pathophysiologic Cascade in Aortic Stenosis

  1. Valve calcification / fibrosis — In degenerative/calcific AS, the process begins with lipid accumulation, inflammation, and calcification of the valve leaflets — a process akin to atherosclerosis. Risk factors overlap with coronary artery disease: hypertension, hyperlipidemia, diabetes, age, male sex, and smoking, as described in current ACC/AHA valvular heart disease guidance.
  2. Progressive narrowing — As calcific deposits accumulate, leaflet mobility decreases, orifice area reduces, and a transvalvular pressure gradient develops. The LV must generate higher systolic pressure to maintain forward output.
  3. Compensatory LV hypertrophy (LVH) — Chronic pressure overload triggers concentric LVH — a compensatory mechanism that initially normalizes wall stress (LaPlace’s law) and preserves LVEF.
  4. Diastolic dysfunction — LVH produces impaired relaxation and increased filling pressures, causing diastolic dysfunction, often before systolic dysfunction develops. This explains why many AS patients have preserved EF even in severe disease.
  5. Decompensation — Eventually the LV dilates, LVEF falls, and the patient enters low-flow low-gradient AS with poor prognosis without intervention.

Aortic Sclerosis vs. Stenosis: Progression Threshold

Aortic sclerosis exists on a continuum with stenosis. The Stewart et al. NEJM/AHA study established that any Doppler peak jet velocity < 2.0 m/s across the aortic valve defines sclerosis (non-obstructive), while ≥ 2.0 m/s with a gradient > 10 mmHg defines stenosis. Annually, about 1–2% of sclerosis cases cross this threshold.

Special Populations

  • Bicuspid aortic valve (BAV): Congenitally abnormal two-cusp morphology accelerates leaflet calcification — typically presenting 10–20 years earlier than tricuspid AS. BAV also confers risk of associated ascending aortopathy.
  • Rheumatic AS: Caused by post-streptococcal inflammation leading to commissural fusion rather than calcification. Almost always associated with mitral valve disease. Coded separately under I06.x per ICD-10-CM convention.
  • Congenital AS: Includes valvular (Q23.0), subvalvular (Q24.4), and supravalvular (Q25.3) forms; often diagnosed in childhood or early adulthood.

💊 Medication Impact / Treatment

Currently, there are no proven medical therapies that halt or reverse the progression of calcific aortic stenosis. This distinguishes AS from conditions where medications play a primary disease-modifying role. Management is therefore focused on symptom control, risk factor optimization, and surveillance — with definitive treatment being mechanical valve replacement.

Pharmacologic Considerations

  • Statins: Despite the pathophysiologic similarity to atherosclerosis, randomized trials (SALTIRE, SEAS) showed no benefit of statin therapy in slowing AS progression. However, statins remain indicated for concurrent atherosclerotic cardiovascular disease (ASCVD).
  • Antihypertensives: ACE inhibitors and ARBs may be used cautiously for concurrent hypertension; however, afterload reduction must be balanced against the risk of hypotension from fixed obstruction. Beta-blockers are used for rate control in concurrent AF or to manage anginal symptoms.
  • Diuretics: Used for symptom management in AS complicated by heart failure (volume overload). Document carefully, as diuretic use in AS context may indicate HF as a complication — an additional reportable diagnosis.
  • Anticoagulation (warfarin / DOACs): Post-SAVR with mechanical prosthesis requires lifelong anticoagulation with warfarin/VKA; DOACs are not used for mechanical valve anticoagulation. After bioprosthetic TAVR without another indication for anticoagulation, low-dose aspirin monotherapy is generally used; DAPT for 3–6 months is a lower-strength option only in selected low-bleeding-risk patients or when otherwise indicated (for example, recent PCI).
  • Vasodilators: Contraindicated or used with extreme caution in severe AS — nitrates and phosphodiesterase inhibitors can cause profound hypotension due to the fixed obstruction.
  • Pre-procedural medications: Dexamethasone (J1100) may be used pre-TAVR to reduce inflammatory responses. Epoetin alfa (J0881) may be used pre-operatively for anemia optimization in SAVR candidates.
📝 Coder Note

When a patient with severe AS is admitted with acute decompensated heart failure, both the AS (I35.0) and the HF type (I50.2x, I50.3x, I50.4x per specificity) should be coded as they represent distinct, independently reportable conditions driving the admission. The HF is a complication of AS — do not absorb one into the other. This can significantly affect MS-DRG assignment and HCC capture.

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides

📘 ICD-10-CM Guidelines

The following coding guidelines apply to aortic stenosis, aortic sclerosis, and related aortic valve conditions under FY2027 ICD-10-CM Official Guidelines for Coding and Reporting.

Etiology: Rheumatic vs. Nonrheumatic

ICD-10-CM distinguishes aortic valve disease by etiology. When the documentation specifies or implies a rheumatic cause (history of acute rheumatic fever, rheumatic heart disease), codes from category I06 apply. When the valve disease is not specified as rheumatic and is presumed degenerative/calcific, category I35 applies. Per Official Guideline Section I.C.9, rheumatic origin should be coded only when documented by the provider. Coders should not assume rheumatic etiology from the presence of mitral valve disease alone.

Congenital Etiology

When aortic stenosis is documented as congenital aortic valve stenosis, assign the appropriate Chapter 17 code from Q00–QA1, such as Q23.0. Per ICD-10-CM Guideline Section I.C.17, congenital malformations, deformations, chromosomal abnormalities, and genetic disorders may be coded throughout the patient’s life when diagnosed by the provider. For a congenital bicuspid or unicuspid aortic valve, assign Q23.81 for the valve morphology and code also any separately documented acquired nonrheumatic aortic valve disorder, such as I35.0, I35.1, or I35.2, when applicable.

Aortic Sclerosis — No Separate Stenosis Code

When documentation clearly states “aortic sclerosis” without stenosis or obstruction, assign I35.8 (Other nonrheumatic disorders of aortic valve). Do not assign I35.0 unless stenosis (hemodynamic obstruction) is documented. Per Official Guidelines, the coder should code to the highest level of specificity supported by documentation; if sclerosis has progressed to stenosis, query to clarify.

Multiple Valve Disease

When both the aortic and mitral valves are involved, or aortic and tricuspid, or all three, use codes from category I08. Category I08 assumes combined/multiple valve disease and takes precedence per the Index and Tabular instructions (see “code first” notes). Assign I08.0 for combined mitral and aortic valve diseases, I08.2 for combined aortic and tricuspid valve diseases, and I08.3 for combined mitral, aortic, and tricuspid valve diseases. Each subcode may be further combined with aortic regurgitation or insufficiency specificity.

Status Codes After Valve Replacement

Following aortic valve replacement (surgical or transcatheter), assign the appropriate heart-valve replacement/status code supported by documentation, commonly Z95.2 (Presence of prosthetic heart valve). Do not assign Z95.810 for TAVR/SAVR status; Z95.810 is for presence of an automatic implantable cardiac defibrillator. If a re-intervention or complication occurs post-TAVR, also consult mechanical complication codes (T82.x).

Severity Documentation — CDI Critical Point

Per UHDDS and Official Guidelines, the severity of AS (mild, moderate, severe, very severe) is not distinguished in the ICD-10-CM code set for nonrheumatic AS — all grades of I35.0 share the same code. However, documenting severity is essential for: (1) HCC risk adjustment (severe AS with HF = multiple HCC capture), (2) MS-DRG differentiation when complications arise, and (3) clinical accuracy for quality measure reporting. CDI should always ensure severity is stated in the record.

🛡️ Audit Alert

Auditors should verify that aortic valve disease coded to I35.x is not of rheumatic origin. When a patient has concurrent mitral valve disease coded to I05.x (rheumatic), any accompanying aortic valve disease should likely be coded to I08.x or I06.x — not I35.x. The ICD-10-CM Tabular includes “Excludes1” and instructional notes differentiating rheumatic and nonrheumatic etiology that must be reviewed.

🔢 ICD-10-CM Code Set (Tabular)

All codes listed are verified for FY2027 per CMS FY2027 ICD-10-CM Tabular List and CDC/NCHS ICD-10-CM files.

ICD-10-CM CodeDescriptionCoding Notes
I35.0Nonrheumatic aortic (valve) stenosisPrimary code for degenerative/calcific AS of any severity; add concurrent HF code (I50.x) if present
I35.1Nonrheumatic aortic (valve) insufficiencyIsolated aortic regurgitation (nonrheumatic); includes aortic regurgitation NOS
I35.2Nonrheumatic aortic (valve) stenosis with insufficiencyUse when both AS and AR are documented; do NOT code I35.0 + I35.1 separately
I35.8Other nonrheumatic disorders of aortic valveAortic sclerosis (non-obstructive); aortic valve calcification without stenosis; aortic valve fibrosis
I35.9Nonrheumatic aortic valve disorder, unspecifiedAvoid — only when etiology and type truly cannot be specified; query if used on final bill
I06.0Rheumatic aortic stenosisRequires documented history of rheumatic fever or rheumatic heart disease as cause of stenosis
I06.1Rheumatic aortic insufficiencyRheumatic aortic regurgitation/incompetence
I06.2Rheumatic aortic stenosis with insufficiencyCombined rheumatic AS and AR; includes stenosis and regurgitation, rheumatic
I06.8Other rheumatic aortic valve diseasesOther specified rheumatic aortic valve conditions
I06.9Rheumatic aortic valve disease, unspecifiedRheumatic aortic valve disease NOS; avoid if more specific rheumatic code available
I08.0Rheumatic disorders of both mitral and aortic valvesCombined MV + AV disease; includes insufficiency, stenosis, or mixed; typically rheumatic
I08.2Rheumatic disorders of both aortic and tricuspid valvesAV + TV combined disease; rheumatic origin
I08.3Combined rheumatic disorders of mitral, aortic and tricuspid valvesTriple valve rheumatic disease; pan-valvular rheumatic heart disease
Q23.0Congenital stenosis of aortic valveUse for documented congenital aortic valve stenosis; applicable across all ages when the congenital condition is still present or affects care; includes congenital aortic atresia and congenital aortic stenosis NOS
Q23.1Congenital insufficiency of aortic valveCongenital aortic regurgitation / incompetence
Q23.4Hypoplastic left heart syndromeSevere hypoplasia of LV, aortic valve, ascending aorta; includes Norwood procedure patients
Q23.81Bicuspid aortic valveCongenital bicuspid aortic valve or unicuspid (congenital) aortic valve at birth; code also any documented acquired nonrheumatic aortic valve disorder, such as I35.0, I35.1, or I35.2, when applicable
Z95.2Presence of prosthetic heart valveProsthetic heart valve status, including supported post-SAVR or post-TAVR status; add when valve status affects care or management
Z95.3Presence of xenogenic heart valveUse when documentation supports presence of a xenogenic/bioprosthetic heart valve; do not use Z95.810 for valve replacement status
📝 Coder Note — MS-DRG Impact

Aortic stenosis coded as a secondary diagnosis with a principal diagnosis of heart failure may trigger MS-DRGs 291–293 (HF with or without MCC/CC). When AS is the reason for a TAVR admission, principal diagnosis is typically I35.0 and the procedure drives MS-DRG 216–221 (cardiac valve procedures). Accurate principal diagnosis selection is critical for MS-DRG optimization and reimbursement.

🔎 Indexing

The ICD-10-CM Alphabetic Index provides the following lead terms and pathways for aortic stenosis and related conditions:

  • Stenosis, stenotic → aortic (valve) → I35.0
    With insufficiency → I35.2; Congenital → Q23.0; Rheumatic → I06.0; Rheumatic with insufficiency → I06.2
  • Sclerosis → aortic (valve) → I35.8 (also see: Endocarditis, aortic)
  • Insufficiency, aortic (valve) → I35.1; Rheumatic → I06.1; Congenital → Q23.1
  • Disease → heart → aortic valve → I35.9; Rheumatic → I06.9
  • Valve → aortic → bicuspid (congenital) → Q23.81
  • Hypoplastic left heart syndrome → Q23.4
  • Presence → prosthetic heart valve → Z95.2
  • History → valve replacement → Z95.2 for prosthetic heart valve status; consider Z95.3 or Z95.4 when documentation supports a more specific heart-valve replacement status; do not use Z95.810 unless an automatic implantable cardiac defibrillator is present

Caution: Index entries for “Calcification, aortic” may lead to I70.0 (Atherosclerosis of aorta). Do not use I70.0 for aortic valve calcification — verify anatomy. Aortic valve calcification (without stenosis) is properly I35.8; aortic artery atherosclerosis is I70.0.

🏥 CPT

The following CPT codes are relevant for aortic stenosis/sclerosis diagnosis, monitoring, and treatment. All codes are verified for CY2027 per the AMA CPT 2027 code set; apply CPT codes by date of service.

CPT CodeDescriptionGlobal PeriodCoding Notes
93306Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiographyXXXPrimary imaging for AS diagnosis and serial surveillance; captures valve morphology, gradient, LVEF, AVA
93350Echocardiography, transthoracic, real-time with image documentation, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physicianXXXStress echo for exercise-induced gradient assessment; useful in low-gradient AS to unmask severity
93351Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professionalXXXComplete stress echocardiography when the stress test component and continuous ECG monitoring/supervision are included; dobutamine stress echo may be used in low-flow/low-gradient AS to assess contractile reserve and true vs. pseudo-severe AS
93452Left heart catheterization including intraprocedural injection(s) for left ventriculography, imaging supervision and interpretation, when performed000LHC for hemodynamic confirmation of AS gradient; coronary angiography assessed prior to SAVR/TAVR
93453Combined right and left heart catheterization including intraprocedural injections for left ventriculography, imaging supervision and interpretation, when performed000Combined RHC + LHC for full hemodynamic assessment; used in complex cases or HF evaluation pre-surgery
33405Replacement, aortic valve, open, with cardiopulmonary bypass; with prosthetic valve other than homograft or stentless valve090Surgical AVR (SAVR) with stented bioprosthetic or mechanical valve; most common open-heart SAVR approach
33406Replacement, aortic valve, open, with cardiopulmonary bypass; with allograft valve (freehand)090SAVR with homograft (cadaveric aortic valve allograft); used in complex endocarditis or young patients
33410Replacement, aortic valve, open, with cardiopulmonary bypass; with stentless tissue valve090Stentless bioprosthetic AVR; hemodynamic advantages in smaller aortic roots
33412Replacement, aortic valve, open, with cardiopulmonary bypass; with autograft (Ross procedure)090Ross procedure: native pulmonary valve moved to aortic position; pulmonic position reconstructed with homograft
33361Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; percutaneous femoral artery approach000Most common TAVR approach; includes all catheter work, device delivery, and valve deployment (transfemoral)
33362TAVR; open femoral artery approach000Femoral cutdown when percutaneous access not feasible
33363TAVR; open axillary artery approach000Axillary/subclavian access; alternative when femoral anatomy precludes transfemoral approach
33364TAVR; open iliac artery approach000Iliac conduit approach; used when femoral and axillary vessels inadequate
33365TAVR; transaortic approach000Direct aortic access through mini-sternotomy or right thoracotomy
33366TAVR; transapical exposure (left thoracotomy)000Transapical approach via left ventricular apex; higher morbidity than transfemoral
33369Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonary bypass support with central arterial and venous cannulation (eg, aorta, right atrium, pulmonary artery) (List separately in addition to code for primary procedure)ZZZAdd-on code for central arterial and venous cannulation cardiopulmonary bypass support; report only with an appropriate primary procedure per CPT instructions
33390Valvuloplasty, aortic valve, open, with cardiopulmonary bypass; simple (without other procedure)090Aortic valve repair without replacement; rarely used for AS; more common for pure AI or in congenital cases
33391Valvuloplasty, aortic valve, open, with cardiopulmonary bypass; complex (eg, leaflet reconstruction)090Complex aortic valve repair; Ozaki procedure or cusp reconstruction techniques
33860Aortic root and ascending aorta reconstruction including valve suspension and coronary ostia mobilization; with valve and root repair090Aortic root reconstruction without valve replacement; used when root pathology coexists with AS (e.g., bicuspid AV aortopathy)
33863Aortic root and ascending aorta reconstruction; with aortic valve replacement (includes valve procurement)090Bentall procedure (composite graft + AVR); for combined AS and aortic root dilation
33864Aortic root and ascending aorta reconstruction; with mechanical or bioprosthetic valve conduit090Modified Bentall/composite conduit procedure; mechanical valve graft
📅 Code-Set Transition — CPT 2026 (dates of service through Dec 31, 2026)
  • 93351: Use the CPT 2026 descriptor for 2026 dates of service; CPT 2027 main table uses the full stress-echocardiography descriptor.
  • 33361–33366: CPT 2026 dates of service retain 000-day global period reporting; CPT 2027 main table continues the 000-day global-period correction.
  • 33369: CPT 2026 descriptor/rule was not “TAVR; not otherwise specified”; CPT 2027 main table identifies 33369 as the add-on code for cardiopulmonary bypass support with central arterial and venous cannulation.

🧾 HCPCS

HCPCS Level II codes are relevant primarily for outpatient hospital and ambulatory surgical center billing of TAVR devices and pre-procedural medications. Verify against the current CMS HCPCS Level II quarterly files and OPPS/APC assignments for the date of service.

HCPCS CodeDescriptionTypical Use / Notes
C1730Cardiovascular, bioprosthetic, pericardial, valve and leaflet replacement, eachOutpatient hospital billing for TAVR bioprosthetic valve devices (e.g., SAPIEN platform); C-codes for pass-through or device-intensive APC billing
C1757Cardiovascular, coronary sinus reduction device, permanent implantableMay apply in select complex cases; verify with device documentation
C1748Endoscope, single-use (i.e., disposable), flexibleNot valve-specific; included for completeness in procedural suites
J0881Injection, darbepoetin alfa, 1 mcg (non-ESRD use)Pre-operative anemia management in SAVR candidates; confirm medical necessity documentation for reimbursement
J0885Injection, epoetin alfa (for non-ESRD use), per 1000 unitsEpoetin alfa for pre-SAVR anemia optimization; requires documented anemia + non-ESRD indication
J1100Injection, dexamethasone sodium phosphate, 1 mgPre-TAVR anti-inflammatory protocol; document indication (pre-procedural inflammatory prophylaxis)
📝 Coder Note — TAVR Device HCPCS

TAVR valve devices (e.g., Edwards SAPIEN 3, Medtronic CoreValve Evolut) are billed with specific C-codes in the outpatient hospital setting under OPPS. The applicable C-code depends on device type and CMS pass-through status; verify current APC assignments annually as these change. In the inpatient setting (IPPS/MS-DRG), device costs are embedded in the DRG payment — separate HCPCS billing does not apply under IPPS.

📚 AHA Coding Clinic

The following guidance from AHA Coding Clinic for ICD-10-CM/PCS is relevant to aortic stenosis and valve procedures. Always verify the most current edition, as guidance is updated quarterly.

  • Coding Clinic — Bicuspid Aortic Valve: Q23.81 was added in FY2022 to provide specificity for congenital bicuspid AV. When a patient has both BAV (Q23.81) and concurrent aortic stenosis (I35.0), both codes should be assigned. The BAV is the underlying etiology of the stenosis and should be coded as an additional diagnosis.
  • Coding Clinic — Aortic Sclerosis vs. Stenosis: Coding Clinic guidance confirms that “aortic sclerosis” without documentation of stenosis or hemodynamic obstruction should be coded to I35.8, not I35.0. Coders should not assume stenosis from sclerosis documentation alone.
  • Coding Clinic — Low-Flow Low-Gradient AS: Guidance recommends querying the provider for severity classification when echocardiographic data and clinical presentation are discordant (e.g., AVA consistent with severe AS but gradient below severe threshold). The final code should reflect the clinician’s documented severity assessment.
  • Coding Clinic — Rheumatic Valve Disease: When aortic and mitral valve disease coexist, coders are directed to use I08.0 (combined mitral and aortic valve disease) rather than separate I05.x and I06.x codes, when the combined code captures the documented conditions.

💰 HCC / Risk Adjustment

Valve disease codes do not map to a V28 payment HCC; any heart failure the valve disease causes is coded and mapped separately. Mappings below follow the 2024 CMS-HCC model (commonly called V28), which CMS uses at 100 percent for non-PACE Medicare Advantage risk scores and continued for CY 2027, and the CMS 2027 Initial ICD-10-CM Mappings. Coefficients vary by enrollee segment and payer, so this guide does not quote RAF weights; check the current CMS model software. Hierarchies are applied by CMS after coding: code every documented, supported condition.

ICD-10-CM Code(s)DescriptionV28 HCCCoding / Documentation Notes
I35.0, I35.1, I35.2, I35.8, I35.9Nonrheumatic aortic valve disorders (stenosis, insufficiency, sclerosis)No V28 payment HCCCode when documented; HCC 224 is acute on chronic heart failure, not valve disease
I06.0–I06.9Rheumatic aortic valve diseasesNo V28 payment HCC—
I08.0–I08.9Multiple valve diseasesNo V28 payment HCC—
Q23.0–Q23.9 (incl. Q23.81)Congenital malformations of aortic and mitral valvesNo V28 payment HCC—
Z95.2, Z95.4Presence of prosthetic or other replacement heart valveNo V28 payment HCC—
I50.21, I50.31, I50.41Acute HF (systolic, diastolic, combined)HCC 225When aortic stenosis causes HF, code the documented HF type and acuity
I50.23, I50.33, I50.43Acute on chronic HFHCC 224HCCs 224–226 share one coefficient
I50.22, I50.32, I50.42, I50.9Chronic or unspecified HFHCC 226—
💬 CDI Query Trigger — Heart Failure in Aortic Stenosis

When a patient with severe aortic stenosis is treated for dyspnea and the attending documents only “aortic stenosis,” a compliant query may ask: “Based on the presentation (dyspnea, reduced exercise tolerance, echo findings), please clarify the diagnosis being treated: heart failure (please specify type and acuity); dyspnea due to aortic stenosis without heart failure; other (please specify); unable to determine.”

Sources: CMS 2027 Initial ICD-10-CM Mappings (2024 CMS-HCC model, V28); CMS CY 2024 Rate Announcement, Attachment VI (hierarchies, constraints, interactions); FY 2027 ICD-10-CM Tabular List, Index, and Official Guidelines Section I.C.9. Verified November 3, 2026.

✍️ CDI Query Templates

All query templates below are written to comply with ACDIS and AHIMA compliant query standards: non-leading, multiple-choice or open-ended, clinically supported, and presented with relevant clinical indicators.

Scenario / Clinical TriggerCompliant Query Wording (Non-Leading)
Echo shows AVA < 1.0 cm², Vmax > 4.0 m/s but provider documents only “aortic stenosis” without severity“Based on the echocardiographic findings (AVA: [X] cm², peak velocity: [X] m/s, mean gradient: [X] mmHg), would you classify the severity of the aortic stenosis as: (a) Mild AS, (b) Moderate AS, (c) Severe AS, (d) Very severe AS, (e) Other/unable to determine? Please document your clinical assessment in the medical record.”
Documentation states “aortic sclerosis” but echocardiographic report shows peak velocity 2.2 m/s and gradient 12 mmHg“Review of the echocardiogram dated [date] shows a peak aortic jet velocity of 2.2 m/s with a gradient of 12 mmHg. Does this represent: (a) Aortic sclerosis (non-obstructive), (b) Mild aortic stenosis, (c) Other — please specify. Please document your clinical interpretation.”
Echocardiogram reports “bicuspid aortic valve” — no query in record; ICD-10 code not in documentation“The echocardiographic report dated [date] describes a bicuspid aortic valve morphology. Is the bicuspid aortic valve: (a) A known prior diagnosis, (b) A new finding, (c) Uncertain/requires further evaluation? If confirmed, please document ‘congenital bicuspid aortic valve’ or equivalent clinical terminology in the record.”
Provider documents “aortic stenosis” — no documentation of rheumatic vs. non-rheumatic; patient has concurrent mitral stenosis“The patient has documented mitral valve disease and aortic valve disease. Regarding the etiology of the aortic valve disease: (a) Rheumatic (related to a history of rheumatic fever or rheumatic heart disease), (b) Non-rheumatic / degenerative / calcific, (c) Both valves rheumatic in etiology, (d) Unable to determine. Documentation of etiology affects accurate code assignment.”
Patient with AS has LVEF 35% with low mean gradient (28 mmHg) and AVA 0.8 cm²“The patient presents with low left ventricular ejection fraction (LVEF 35%), a mean aortic gradient of 28 mmHg, and an aortic valve area of 0.8 cm². Does this represent: (a) Severe aortic stenosis with reduced LVEF (classic low-flow low-gradient AS), (b) Pseudo-severe aortic stenosis (non-severe AS with reduced LVEF from another cause), (c) Moderate aortic stenosis, (d) Other — please specify. A dobutamine stress echo may assist in differentiation.”
Dyspnea documented in a patient with severe AS — no HF documented“The patient has documented severe aortic stenosis and presents with dyspnea. Does the patient have concurrent: (a) Systolic (reduced LVEF) heart failure, (b) Diastolic (preserved LVEF) heart failure, (c) Both systolic and diastolic heart failure, (d) Dyspnea attributable solely to AS without heart failure at this time, (e) Other — please specify.”
History of TAVR/SAVR documented in notes but not in final diagnoses or problem list“The medical record references a prior aortic valve replacement procedure. Is the patient’s current status: (a) Post-TAVR (transcatheter aortic valve replacement), (b) Post-SAVR (surgical aortic valve replacement — mechanical prosthesis), (c) Post-SAVR (surgical aortic valve replacement — bioprosthetic), (d) No prior valve procedure — documentation requires correction. Please confirm and document current valve status.”

🧑‍⚕️ Treatments (Clinical)

Treatment decisions in aortic stenosis are guided by the 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease. Intervention thresholds depend on symptom status, severity classification, LVEF, and patient surgical risk.

Surveillance (Asymptomatic AS / Aortic Sclerosis)

  • Aortic sclerosis: Annual clinical evaluation; echocardiogram every 3–5 years or when symptoms develop
  • Mild AS: Echocardiogram every 3–5 years; optimize cardiovascular risk factors
  • Moderate AS: Echocardiogram every 1–2 years; exercise testing may be considered
  • Severe AS (asymptomatic): Echo every 6–12 months; strong consideration for intervention when rapid progression, LVEF < 60%, or very high gradient (Class IIa/IIb indications per 2021 AHA/ACC)

Aortic Valve Replacement (AVR) — Intervention Thresholds

  • Class I (AVR recommended): Symptomatic severe AS (any symptom from the classic triad); severe AS with LVEF < 50%; severe AS undergoing other cardiac surgery
  • Class IIa (AVR reasonable): Asymptomatic very severe AS (Vmax ≥ 5.0 m/s); moderate AS undergoing other cardiac surgery; severe AS with abnormal exercise test

TAVR vs. SAVR Selection

Per the 2021 ACC/AHA guidelines and subsequent randomized trial data (PARTNER 3, Evolut Low Risk), TAVR is indicated for severe AS across all surgical risk categories in appropriate anatomy. The heart team’s shared decision-making determines TAVR vs. SAVR based on:

  • Surgical risk (STS PROM score): High risk (>8%) or prohibitive → TAVR preferred; Low/intermediate risk → TAVR comparable to SAVR at 5-year outcomes
  • Anatomy: Favorable femoral access, adequate annulus size, no severe calcium in LVOT
  • Life expectancy: Younger patients (<65 years) may benefit from SAVR with mechanical valve for durability; older patients (>75–80) generally TAVR preferred
  • BAV anatomy: Previously a relative contraindication to TAVR; now approached at experienced centers with careful planning

Balloon Aortic Valvuloplasty (BAV)

Percutaneous balloon aortic valvuloplasty (not to be confused with the condition aortic sclerosis) provides temporary relief of AS gradient. Its use is limited to bridge-to-TAVR/SAVR in hemodynamically unstable patients, or as palliative therapy in patients not candidates for definitive replacement. CPT 92986 (percutaneous BAV) applies when this procedure is performed.

Management of Post-Valve Replacement Patients

  • Mechanical prosthesis: Lifelong anticoagulation (warfarin, target INR 2.5–3.5 for aortic position)
  • Bioprosthetic SAVR: Antiplatelet therapy for 3–6 months, then aspirin; anticoagulation only if concurrent AF
  • Post-TAVR: Low-dose aspirin monotherapy is generally used when there is no other indication for anticoagulation or DAPT; use oral anticoagulation when independently indicated (for example, atrial fibrillation), and avoid routine low-dose rivaroxaban plus aspirin in patients without another anticoagulation indication (GALILEO harm signal).
  • Surveillance for structural valve deterioration (SVD): Serial echocardiography per guideline schedule

🎓 Patient Education / Summary

The following patient-facing summary can be used by clinical documentation specialists and educators to explain aortic stenosis and coding concepts at a lay level. It may be adapted for patient education materials.

What Is Aortic Stenosis?

The aortic valve is like a door between your heart’s main pumping chamber (left ventricle) and the large artery (aorta) that carries blood to your body. In aortic stenosis, this door becomes stiff and narrowed — usually from calcium buildup — making the heart work much harder to push blood through. Over time, this extra strain can weaken the heart and cause symptoms like chest pain, dizziness, and shortness of breath.

What Is Aortic Sclerosis?

Aortic sclerosis means the aortic valve leaflets have thickened or have some calcium deposits, but the valve opening is still wide enough that blood flows through easily. Think of it as the “early warning stage” — the valve is changing, but it’s not yet causing a blockage. About 1 in 100 people with aortic sclerosis will develop true stenosis each year. Regular monitoring with echocardiography (heart ultrasound) is recommended.

Why Does the Coding Distinction Matter for Patients?

Accurate coding ensures that your health records reflect the true severity of your condition. This affects the care plan, reimbursement for treatments, and Medicare risk scores that determine how much funding is available for your care. When doctors document severity (mild, moderate, or severe), coders and insurers can ensure the right resources are in place.

Treatment Overview for Patients

  • Mild to moderate AS: Regular monitoring, heart-healthy lifestyle, management of blood pressure and cholesterol
  • Severe AS with symptoms: Aortic valve replacement is typically recommended — either open-heart surgery (SAVR) or minimally invasive catheter-based procedure (TAVR)
  • After valve replacement: Medications (blood thinners or antiplatelets), follow-up echocardiograms, activity guidance, and endocarditis prevention (dental prophylaxis in some cases)
📝 Patient Communication Note for CDI

When educating patients about their diagnosis, emphasize the importance of symptom reporting — patients with severe AS may underreport symptoms or attribute them to aging. Early symptom recognition triggers timely intervention referrals, improves outcomes, and ensures complete clinical documentation that reflects the true burden of disease.


About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2027 ICD-10-CM (effective October 1, 2026). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: October 2026 · Next scheduled review: September 2027 (FY2028 update)

Ready to turn this knowledge into a credential?

These Clinical Documentation Guides are a free companion to CCO’s paid training programs. Browse our full CCO Course, Blitz & Practice Exam Catalog — every core course, review blitz, practice exam, textbook, and free resource in one place — and find the perfect next step for your coding career.

CCO Hero

Know someone starting a medical coding career?

Share your personal CCO link. Your friend saves 20% on their first course or practice exam of $100 or more, and you earn 5% cash on their first enrollment over $100.

Become a CCO Hero
Photo of author

CCO Certified Professionals

The CCO Certified Professionals team brings together experienced, credentialed medical coders, CDI specialists, and clinical documentation experts with decades of combined expertise in inpatient, outpatient, and risk-adjustment coding. Every Clinical Documentation Guide is built and reviewed by certified instructors who teach, code, and audit in the field every day. Content is verified against current ICD-10-CM, AHA Coding Clinic, and CMS guidance.

Leave a Comment

Clinical Doc Guides

⚊